MaaT Pharma

OverviewSuggest Edit

MaaT Pharma (Microbiota as a Therapy) is a French biotech start-up, created at the end of 2014, to treat serious diseases linked to imbalances in the intestinal microbiome. It has developed the first treatment solution based on autologous microbiotherapy. MaaT Pharma envisages a first therapeutic application for patients suffering from leukaemia and bone & joint infections, whose major treatment contributes to dysbiosis. Funded jointly by a team which brings together world-class medical-scientific and entrepreneurial skills, MaaT Pharma has the ambition of becoming a leader in microbiome protection and the treatment of dysbiosis.
TypePrivate
Founded2014
HQLyon, FR
Websitemaatpharma.com

Latest Updates

Employees (est.) (Nov 2020)30(+4%)
Cybersecurity ratingBMore

Key People/Management at MaaT Pharma

Herve Affagard

Herve Affagard

Chief Executive Officer & Co Founder and Director
John Weinberg

John Weinberg

Chief Medical Officer
Siân Crouzet

Siân Crouzet

Chief Operations Officer
Savita Bernal

Savita Bernal

Chief Business Officer
Eric de la Fortelle

Eric de la Fortelle

Non-Executive Director
Julien Samson

Julien Samson

Independent Non-Executive Director
Show more

MaaT Pharma Office Locations

MaaT Pharma has offices in Lyon and Lyon-7E-Arrondissement
Lyon, FR (HQ)
69 Avenue Jean Jaurès
Lyon-7E-Arrondissement, FR (HQ)
317 Avenue Jean Jaurès
Show all (2)

MaaT Pharma Financials and Metrics

Summary Metrics

Founding Date

2014

MaaT Pharma total Funding

$32.1 m

MaaT Pharma latest funding size

$19.81 m

Time since last funding

10 months ago

MaaT Pharma investors

MaaT Pharma's latest funding round in February 2020 was reported to be $19.8 m. In total, MaaT Pharma has raised $32.1 m
Show all financial metrics

MaaT Pharma Cybersecurity Score

Cybersecurity ratingPremium dataset

B

89/100

SecurityScorecard logo

MaaT Pharma Online and Social Media Presence

Embed Graph

MaaT Pharma Blogs

MaaT Pharma to Provide Data Update for Lead Microbiome Biotherapeutic in Oral Presentation at 62nd American Society of Hematology (ASH) Annual Meeting

The post MaaT Pharma to Provide Data Update for Lead Microbiome Biotherapeutic in Oral Presentation at 62nd American Society of Hematology (ASH) Annual Meeting appeared first on MaaT Pharma.

MaaT Pharma Treats First Acute Myeloid Leukemia Patient in Phase 1 Clinical Trial to Evaluate Capsule Formulation of Microbiome Restoration Biotherapeutic

The post MaaT Pharma Treats First Acute Myeloid Leukemia Patient in Phase 1 Clinical Trial to Evaluate Capsule Formulation of Microbiome Restoration Biotherapeutic appeared first on MaaT Pharma.

MaaT Pharma Announces Positive Data for its Lead Microbiome Biotherapeutic MaaT013 in Intestinal Acute Graft-versus-Host-Disease at the Virtual 46th Annual Meeting of the EBMT

The post MaaT Pharma Announces Positive Data for its Lead Microbiome Biotherapeutic MaaT013 in Intestinal Acute Graft-versus-Host-Disease at the Virtual 46th Annual Meeting of the EBMT appeared first on MaaT Pharma.

Posters – EBMT 2020 Virtual

The post Posters – EBMT 2020 Virtual appeared first on MaaT Pharma.

MaaT Pharma to Announce Clinical Data with its Lead Microbiota Biotherapeutic in Intestinal Acute GvHD at Virtual 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)

The post MaaT Pharma to Announce Clinical Data with its Lead Microbiota Biotherapeutic in Intestinal Acute GvHD at Virtual 46th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) appeared first on MaaT Pharma.

MaaT Pharma Announces Initiation of New Collection and Manufacturing Campaign for its Microbiome Biotherapeutic Product Portfolio

The post MaaT Pharma Announces Initiation of New Collection and Manufacturing Campaign for its Microbiome Biotherapeutic Product Portfolio appeared first on MaaT Pharma.
Show more

MaaT Pharma Frequently Asked Questions

  • When was MaaT Pharma founded?

    MaaT Pharma was founded in 2014.

  • Who are MaaT Pharma key executives?

    MaaT Pharma's key executives are Herve Affagard, John Weinberg and Siân Crouzet.

  • How many employees does MaaT Pharma have?

    MaaT Pharma has 30 employees.

  • Who are MaaT Pharma competitors?

    Competitors of MaaT Pharma include Waters, Hello Heart and Oura.

  • Where is MaaT Pharma headquarters?

    MaaT Pharma headquarters is located at 69 Avenue Jean Jaurès, Lyon.

  • Where are MaaT Pharma offices?

    MaaT Pharma has offices in Lyon and Lyon-7E-Arrondissement.

  • How many offices does MaaT Pharma have?

    MaaT Pharma has 2 offices.